Expanding Heart Failure Survival Through Team-Based Care
Integrating pharmacists and nurse practitioners into heart failure care could slash hospital admissions and boost survival rates, according to an economic model published in the Canadian Journal of Cardiology. The study suggests that shifting medication management to these professionals offers a cost-effective path to closing critical gaps in guideline-directed medical therapy.
The Growing Burden on the Canadian Health System
Heart failure currently affects approximately 860,000 Canadians. It is the third-leading cause of hospitalization in the country, with roughly half of these patients suffering from heart failure with reduced ejection fraction (HFrEF).
Clinical standards dictate “quadruple therapy”—the rapid initiation of four specific medication classes. Yet, many patients fall through the cracks. Researchers point to inadequate access to heart failure specialists and clinics as a barrier to optimal care.
Led by Ricky Turgeon of the University of British Columbia’s Faculty of Pharmaceutical Sciences, the research team modeled a collaborative approach that moves beyond traditional physician-led GDMT management. The data is striking: for every 1,000 patients, delegating medication management to pharmacists and nurse practitioners would save approximately 10 lives within the first year and prevent 25 hospitalizations.
Turgeon acknowledges that the service requires new funding, but argues the investment pays for itself through clinical outcomes and system efficiency. “Pharmacists and nurse practitioners are important members of the health care team who can help improve medication use for heart failure,” Turgeon stated.
A Scalable Roadmap for Provincial Health Authorities
The model provides a blueprint for provinces to address persistent gaps in care. By empowering pharmacists and nurse practitioners to deliver gold-standard treatments, the system can improve efficiency.
Kelly Mackay, co-lead investigator with Cardiac Services BC, Provincial Health Services Authority, noted that the findings offer the evidence required for system-wide innovation. Nathaniel Hawkins, also of Cardiac Services BC, Provincial Health Services Authority, and the University of British Columbia, confirmed the model could be successful in other Canadian provinces, promising both reduced strain on hospital resources and improved patient longevity.
Clarifying the Clinical Approach
What is guideline-directed medical therapy (GDMT)?
GDMT refers to the standard of care for heart failure, which involves the rapid initiation of four distinct classes of medication collectively known as quadruple therapy.
Why are pharmacists and nurse practitioners involved in this model?
Because access to heart failure specialists and clinics is often limited, pharmacists and nurse practitioners can fill critical gaps by initiating and managing medications, ensuring patients receive timely and appropriate treatment.
Is this model considered cost-effective?
Yes. According to the study, the clinical benefits justify the additional costs required to fund these expanded roles within the Canadian health care system.